BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
BioPharm Executive - Karl Thiel
BioPharm Executive: Job Inversion: The Impact of Pharma Offshoring 6/25/2014
Back To The Future: The Revenge Of Gene Therapy 5/29/2014
Job Seekers Take Notice: Pharma Megamergers Could Be Back 4/30/2014
BioPharm Executive: Eli Lilly and Company (LLY) CEO: Unqualified Scientists In The STEM Market 2/26/2014
BioPharm Executive: Will 2014 Be The Year For RNA Companies? 1/29/2014
BioPharm Executive: Lucky 2013: The Biotech Year In Review 12/18/2013
BioPharm Executive: The Coming Antibiotic Crisis: Should Biotech Follow Its Gut? 11/27/2013
BioPharm Executive: Layoffs Haunt Biotech as Dust Settles After Shutdown 10/31/2013
BioPharm Executive: Google Inc.'s Mysterious Calico Thinks It Can Cheat Death 9/25/2013
BioPharm Executive: Not All States are Biosimilar 8/28/2013
BioPharm Executive: Bribery, Fraud, Deceit--Just Another Day in Pharmaland 7/31/2013
BioPharm Executive: Here's to Elan Corporation PLC (ELN): Is it a Toast or a Wake? 6/26/2013
BioPharm Executive: Manufacturing Trouble: Moving From Crisis to Crisis 5/29/2013
BioPharm Executive: Myriad Genetics, Inc. (MYGN), Glivec, and the $1 Billion "Myth" 4/25/2013
BioPharm Executive: Speaking the Unspeakable 3/27/2013
BioPharm Executive: The End Is Near 2/27/2013
BioPharm Executive: Good Things Ahead 1/30/2013
BioPharm Executive: 2012 in Review 12/19/2012
BioPharm Executive: Pharma Embraces Emerging Markets; They Don't Embrace Back 9/26/2012
BioPharm Executive: Patent Threats, and the Cheap Cost of R&D 8/30/2012
BioPharm Executive: 6 Ways to Save Biotech 7/25/2012
BioPharm Executive: The Price of Togetherness 6/27/2012
BioPharm Executive: Your American Society of Clinical Oncology Crib Sheet 5/30/2012
BioPharm Executive: Shareholders Before Patients? 4/25/2012
BioPharm Executive: Smaller is Smarter 3/28/2012
BioPharm Executive: Bubble, Billions, or Both? 2/29/2012
BioPharm Executive: Embracing Generics and Emerging Markets 1/25/2012
BioPharm Executive: Top 10: 2011 in Review 12/14/2011
BioPharm Executive: The Bad Old Days in Europe? 11/30/2011
BioPharm Executive: FDA Gets the Message 10/26/2011
BioPharm Executive: Too Big to Succeed? 9/29/2011
BioPharm Executive: The Price of Confusion 9/1/2011
BioPharm Executive: FDA, Faster Than Ever? 7/28/2011
BioPharm Executive: Everything You Wanted to Know About ASCO (But Were Afraid to ASCO) 5/25/2011
Biopharm Executive: Too Big to Be Responsible? 4/28/2011
BioPharm Executive: Pure, Small Pharma 3/30/2011
BioPharm Executive: We're All In This Together 2/23/2011
BioPharm Executive: Going Mobile 1/27/2011
BioPharm Executive: Top 10: 2010 In Review 12/15/2010
BioPharm Executive: The Acceleration of Disgust 11/24/2010
BioPharm Executive: Lilly's Shopping Plans Go Against the Grain 10/27/2010
BioPharm Executive: Is Cancer's "Penicillin Moment" FDA's Moment of Doubt? 9/29/2010
BioPharm Executive: Lilly, By Any Other Name... 8/25/2010
BioPharm Executive: Firing Slows, but Lilly Fans the Flames 7/29/2010
BioPharm Executive: Clean Up Your Act 6/30/2010
BioPharm Executive: Hurry Up and Wait 4/28/2010
BioPharm Executive: The New Decade Finally Begins 3/31/2010
BioPharm Executive: This Is Recovery: Less Money, Less Risk Appetite, Fewer Jobs 2/24/2010
BioPharm Executive: J.P. Morgan Healthcare Conference Sets the Tone for 2010 1/27/2010
BioPharm Executive: Top 10: 2009 In Review 12/21/2009
BioPharm Executive: Where'd the Jobs Go? 11/25/2009
BioPharm Executive: No Sleep, But Plenty of REMS 10/28/2009
BioPharm Executive: Vivus: Savior of the Pharma Industry? 9/30/2009
BioPharm Executive: Biotech's Dog Days 8/26/2009
BioPharm Executive: Sunshine, Lollipops, and Exclusivity 7/21/2009
BioPharm Executive: Sprinting to the Finish 6/30/2009
BioPharm Executive: Biotech's Green Shoots 5/27/2009
BioPharm Executive: We Are All Activists Now 4/29/2009
BioPharm Executive -- Biogenerics: The Time Has Come 3/31/2009
BioPharm Executive: Big Pharma's Musical Chairs 2/25/2009
BioPharm Executive: Off On the Right Hand in 2009 1/28/2009
BioPharm Executive Top 10: 2008 in Review 12/18/2008
BioPharm Executive: Change Comes to Biotech 11/25/2008
BioPharm Executive: No Free Lunch 10/29/2008
BioPharm Executive: There Goes Wall Street 9/30/2008
BioPharm Executive: Biotech Money Goes to Democrats (Plus the Stupid Drug Name Olympics) 8/27/2008
BioPharm Executive: Rethink Everything 7/30/2008
Small is Beautiful -- BioPharm Executive 6/25/2008
Taking the Gloves Off 5/26/2008
Biotech Blossoms Anew 4/30/2008
Time to Buy Biotech? 3/26/2008
Biogenerics in '08? 2/26/2008
Keeping Your Hands Clean 1/23/2008
Desperate But Not Crazy 12/20/2007
Dinosaurs and Drug Companies 11/20/2007
Party Like It's 1999 10/23/2007